title: EGF mutant receptor vIII as a molecular target in cancer therapy.
authors.affiliation: Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.
authors.forename: C T
authors.initials: CT
authors.lastname: Kuan
authors.forename: C J
authors.initials: CJ
authors.lastname: Wikstrand
authors.forename: D D
authors.initials: DD
authors.lastname: Bigner
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D066246:ErbB Receptors / Q000235:genetics / Q000276:immunology*; D015972:Gene Expression Regulation, Neoplastic; D005909:Glioblastoma / Q000276:immunology / Q000628:therapy; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D000922:Immunotoxins / Q000276:immunology / Q000627:therapeutic use; D009154:Mutation; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; C410723:epidermal growth factor receptor VIII; D066246:ErbB Receptors